Filters: keyword is Time Factors [Clear All Filters]
- 2009
Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex,
Anesthesiology, vol. 110, no. 1, pp. 95-105.
- 2008
Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients,
Clin Pharmacol Ther, vol. 83, no. 3, pp. 443-51.
- 1999
Pilot study in humans on the pharmacokinetics and safety of propofol 6% SAZN,
Pharm World Sci, vol. 21, no. 5, pp. 239-40.
- 1991
Biophase equilibration times,
J Pharm Sci, vol. 80, no. 9, pp. 881-6.
A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat,
J Pharmacokinet Biopharm, vol. 19, no. 5, pp. 485-96.
- 1990
Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis,
J Pharmacokinet Biopharm, vol. 18, no. 5, pp. 459-81.
- 1988
- 1984
Kinetics of drug action in disease states. I. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex,
J Pharmacol Exp Ther, vol. 229, no. 1, pp. 44-50.
- 1983
Disposition of hexobarbital in the rat. Estimation of "first-pass" elimination and influence of ether anesthesia,
J Pharmacol Exp Ther, vol. 226, no. 1, pp. 201-5.
- 1979
Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers,
Br J Clin Pharmacol, vol. 8, no. 6, pp. 529-37.



